Jingdong Zhang

Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer

Jianming Xu, Haiping Jiang, Yueyin Pan et al. · JAMA · 2023 · 300 citations · Full text

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study

Jianming Xu, Ken Kato, Eric Raymond et al. · The Lancet Oncology · 2023 · 248 citations

Chemotherapy Versus Placebo, Esophageal Cancer, Gastrointestinal Oncology +8

PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells

Dan Li, Xiujuan Qu, Kezuo Hou et al. · Anti-Cancer Drugs · 2008 · 157 citations

Gastric Cancer Cells, Cell Regulation, Human Leukemia +15

How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy.

Yiming Ma, Qiwei Wang, Qian Dong et al. · PubMed · 2019 · 152 citations · Full text

Cancer Management, Immunology, Immunoediting +18

First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial

Yan Song, Bo Zhang, Dao Xin et al. · Nature Medicine · 2023 · 149 citations · Full text